GVHD, ACUTE

Clinical trials for GVHD, ACUTE explained in plain language.

Never miss a new study

Get alerted when new GVHD, ACUTE trials appear

Sign up with your email to follow new studies for GVHD, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1

New drug combo shows promise in preventing transplant complications

Disease control Completed

This early-phase study tested whether adding a drug called BMS-986004 (which blocks CD40-L) to standard immune-suppressing medicine could help prevent acute graft-versus-host disease (GVHD) in 45 adults with blood cancers or disorders receiving a stem cell transplant. GVHD is a s…

Matched conditions: GVHD, ACUTE

Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated May 11, 2026 20:48 UTC

GVHD, ACUTE

Get alerted when new GVHD, ACUTE trials appear

New drug combo shows promise in preventing transplant complications